Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-020762
Filing Date
2014-03-14
Accepted
2014-03-14 19:03:30
Documents
1
Period of Report
2014-03-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 12619
  Complete submission text file 0001209191-14-020762.txt   13955
Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850 (301) 795-1800
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2273 RESEARCH BLVD, SUITE 400 ROCKVILLE MD 20850
Business Address
El-Hibri Fuad (Reporting) CIK: 0001380185 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 14695769